The independent source for health policy research, polling, and news.
741-760 of 3,363 results
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
The 25-bed hospital in Crockett, Texas, abruptly closed its doors in 2017, joining the ranks of nearly 100 rural hospitals that have shut down in the past decade. But the community kept the faith and several doctors reopened the facility this year.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
The new rule took effect Jan. 1 but, for consumers seeking hospital price information, using it to find answers may be like searching for a needle in a haystack.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
Managed-care plans, which reap billions in taxpayer dollars to coordinate care for low-income Americans on Medicaid, outsource crucial treatment decisions to subcontractors that aren’t directly accountable to the government. In California, health officials say one firm improperly withheld or delayed care for hundreds of people.
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
An Arizona couple played by the rules and bought employer-provided health insurance. But after they had a baby this year, their out-of-pocket hospital costs and doctors’ bills climbed to more than $12,000 — and medical debt now threatens their new family.
After a 34-year-old woman suffered a stroke in Kansas, doctors there arranged for her to be transferred to a Boston hospital, via an Angel MedFlight Learjet. The woman and her father believed the cost of the medical flight would be covered by her private insurance. Then they got the bill.
Ski buff Sarah Witter will get $6,358.26 back from her hospital and insurer after a careful review of her bill following the KHN-NPR story on her case.
Trump administration efforts to undo Obama-era rules have helped create the buzz around this type of health coverage.
A crowdsourced investigation in which we dissect, investigate and explain medical bills you send us.
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.
As the number of people who inject drugs has soared, the rate of hepatitis C infection has climbed steeply, too, because the disease can be tied to sharing needles. Yet many drug patients are not checked for the virus that can damage the liver.
She took a bad fall on the slopes and her surgeon used a metal plate to put the splintered bones of her leg back together. When that device failed less than four months later, she and her insurer had to pay full price for the replacement plate.
The Lone Star State is an economic powerhouse, yet it fails to take care of its residents’ health and is home to some of the most extreme entrepreneurial medical practices.
The leaders of California’s legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
© 2026 KFF